Downregulation of microRNA-15b-5p Targeting the Akt3-Mediated GSK-3β/β-Catenin Signaling Pathway Inhibits Cell Apoptosis in Parkinson’s Disease

Bax, Bak and beyond - mitochondrial performance in apoptosis

(2017) Aida Peña-Blanco et al.   FEBS Journal

Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson’s disease

(2017) Gunasingh J. Masilamoni et al.   JOURNAL OF NEURAL TRANSMISSION

Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3

(2017) Chengcheng Zhao et al.   ONCOLOGY REPORTS

Modern conception of the pathogenesis of neurodegenerative diseases and therapeutic strategy

(2017) I. V. Litvinenko et al.   Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova

OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways

(2017) Hua Li et al.   Oncotarget

Serum miR-221 serves as a biomarker for Parkinson's disease

(2016) Wenbin Ma et al.   CELL BIOCHEMISTRY AND FUNCTION

Protein Folding and Misfolding, Endoplasmic Reticulum Stress in Neurodegenerative Diseases: in Trace of Novel Drug Targets

(2016) Botond Penke et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease

(2016) Aaron D. Thome et al.   JOURNAL OF NEUROSCIENCE

Role of Dicer and the miRNA system in neuronal plasticity and brain function

(2016) Anna Fiorenza et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt/GSK3b/b-catenin pathway

(2015) Ying Ying et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection

(2015) Uma A. Mukherjee et al.   PHARMACOLOGY & THERAPEUTICS

Aberrant regulation of miR-15b in human malignant tumors and its effects on the hallmarks of cancer

(2015) Ci Zhao et al.   TUMOR BIOLOGY

miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A

(2015) Yang Yang et al.   Oncotarget

Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases

(2014) Lin Tan et al.   MOLECULAR NEUROBIOLOGY

Emerging therapies for Parkinson's disease: From bench to bedside

(2014) F.I. Tarazi et al.   PHARMACOLOGY & THERAPEUTICS

miR-15b Suppression of Bcl-2 Contributes to Cerebral Ischemic Injury and is Reversed by Sevoflurane Preconditioning

(2013) Hong Shi et al.   CNS & Neurological Disorders-Drug Targets

Circulating miRNA Biomarkers for Alzheimer's Disease

(2013) Pavan Kumar et al.   PLoS One

Neuronal dark matter: the emerging role of microRNAs in neurodegeneration

(2013) Emily F. Goodall et al.   Frontiers in Cellular Neuroscience

The involvement of microRNAs in neurodegenerative diseases

(2013) Simona Maciotta et al.   Frontiers in Cellular Neuroscience

MicroRNAs: Possible role in pathogenesis of Parkinson’s disease

(2012) E. V. Filatova et al.   BIOCHEMISTRY-MOSCOW

MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3

(2012) Xuguang Zheng et al.   CANCER LETTERS

The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease

(2010) Toru Yasuda et al.   APOPTOSIS

Biological functions of microRNAs: a review

(2010) Yong Huang et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Repression of  -synuclein expression and toxicity by microRNA-7

(2009) E. Junn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA